While CDH13 methylation has not yet been directly associated with prognosis in breast cancer, CDH13 methylation has been associated with HER2 amplification [52] and negative PgR status [15] in invasive breast carcinoma, although the latter relationship was not confirmed in a subsequent study by the same group [53]. Here, CDH13 is linked to breast carcinoma.